475 related articles for article (PubMed ID: 10946317)
21. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
Stephens LA; Kay TW
Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
[TBL] [Abstract][Full Text] [Related]
22. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
Balasa B; Lee J; Sarvetnick N
Cell Immunol; 1999 May; 193(2):170-8. PubMed ID: 10222059
[TBL] [Abstract][Full Text] [Related]
23. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice.
Kägi D; Odermatt B; Seiler P; Zinkernagel RM; Mak TW; Hengartner H
J Exp Med; 1997 Oct; 186(7):989-97. PubMed ID: 9314549
[TBL] [Abstract][Full Text] [Related]
24. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
25. Islet expression of perforin, Fas/Apo-1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice.
Ingelsson E; Saldeen J; Welsh N
Immunol Lett; 1998 Oct; 63(3):125-9. PubMed ID: 9840679
[TBL] [Abstract][Full Text] [Related]
26. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
27. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse.
Balasa B; Van Gunst K; Jung N; Katz JD; Sarvetnick N
Cell Immunol; 2000 Jun; 202(2):97-102. PubMed ID: 10896769
[TBL] [Abstract][Full Text] [Related]
28. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
Sainio-Pöllänen S; Liukas A; Pöllänen P; Simell O
Pancreas; 1999 Apr; 18(3):282-93. PubMed ID: 10206487
[TBL] [Abstract][Full Text] [Related]
29. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
30. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.
Wogensen L; Lee MS; Sarvetnick N
J Exp Med; 1994 Apr; 179(4):1379-84. PubMed ID: 8145050
[TBL] [Abstract][Full Text] [Related]
31. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine.
Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K
Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872
[TBL] [Abstract][Full Text] [Related]
32. Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic mice.
Wang JL; Qian X; Chinookoswong N; Lu J; Chow G; Theill LE; Shi ZQ
Endocrinology; 2002 Sep; 143(9):3490-7. PubMed ID: 12193562
[TBL] [Abstract][Full Text] [Related]
33. Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice.
Allison J; Thomas HE; Catterall T; Kay TW; Strasser A
J Immunol; 2005 Jul; 175(1):293-301. PubMed ID: 15972661
[TBL] [Abstract][Full Text] [Related]
34. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.
Robey IF; Peterson M; Horwitz MS; Kono DH; Stratmann T; Theofilopoulos AN; Sarvetnick N; Teyton L; Feeney AJ
J Immunol; 2004 Apr; 172(7):4624-9. PubMed ID: 15034081
[TBL] [Abstract][Full Text] [Related]
35. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice.
Moritani M; Yoshimoto K; Tashiro F; Hashimoto C; Miyazaki J; Ii S; Kudo E; Iwahana H; Hayashi Y; Sano T
Int Immunol; 1994 Dec; 6(12):1927-36. PubMed ID: 7696210
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: no role of Fas-Fas ligand interaction in autoimmune diabetes.
Kim YH; Kim S; Kim KA; Yagita H; Kayagaki N; Kim KW; Lee MS
Eur J Immunol; 1999 Feb; 29(2):455-65. PubMed ID: 10064061
[TBL] [Abstract][Full Text] [Related]
37. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse.
Thomas HE; Irawaty W; Darwiche R; Brodnicki TC; Santamaria P; Allison J; Kay TW
Diabetes; 2004 Jan; 53(1):113-21. PubMed ID: 14693705
[TBL] [Abstract][Full Text] [Related]
38. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
[TBL] [Abstract][Full Text] [Related]
39. Fas is detectable on beta cells in accelerated, but not spontaneous, diabetes in nonobese diabetic mice.
Darwiche R; Chong MM; Santamaria P; Thomas HE; Kay TW
J Immunol; 2003 Jun; 170(12):6292-7. PubMed ID: 12794162
[TBL] [Abstract][Full Text] [Related]
40. Fas deficiency prevents type 1 diabetes by inducing hyporesponsiveness in islet beta-cell-reactive T-cells.
Vence L; Benoist C; Mathis D
Diabetes; 2004 Nov; 53(11):2797-803. PubMed ID: 15504959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
